Education
About Us
Working with TipRanks
Follow Us
Sangui BioTech International Inc (SGBI)
OTHER OTC:SGBI
SGBI Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume1.15K
Average Volume (3M)293.34K
Market Cap
$119.53K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)760.97K
Price to Earnings (P/E)―
Beta0.92
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding209,901,840
10 Day Avg. Volume293,337
30 Day Avg. Volume293,337
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
SGBI FAQ
What was Sangui BioTech International Inc’s price range in the past 12 months?
Sangui BioTech International Inc lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Sangui BioTech International Inc’s market cap?
Sangui BioTech International Inc’s market cap is $119.53K.
When is Sangui BioTech International Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sangui BioTech International Inc’s earnings last quarter?
Currently, no data Available
Is Sangui BioTech International Inc overvalued?
According to Wall Street analysts Sangui BioTech International Inc’s price is currently Overvalued.
Does Sangui BioTech International Inc pay dividends?
Sangui BioTech International Inc does not currently pay dividends.
What is Sangui BioTech International Inc’s EPS estimate?
Sangui BioTech International Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sangui BioTech International Inc have?
Sangui BioTech International Inc has 209,901,840 shares outstanding.
What happened to Sangui BioTech International Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sangui BioTech International Inc?
Currently, no hedge funds are holding shares in SGBI
---
Company Description
Sangui BioTech International Inc
Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.
---
Technical Analysis
Qiagen
―
DMG MORI AKTIENGESELLSCHAFT
―
Evotec
―
Fresenius Medical Care AG & Co. KGaA
―
Sartorius
―
---